Comparative Research Among 3 Action Protocol in Other to Approach Chronic Patellar Tendinopathy
Trial Snapshot
- Phase
- Not Applicable
- Status
- Completed
- Sponsor
- Universidad de Zaragoza
- Enrollment
- 50
- Locations
- 1
- Primary Endpoint
- Change from baseline in functionality at 8 weeks as measured by Visa-p
Study Overview
Brief Summary
The accomplishment of a treatment with Intratissue Percutaneous Electrolysis of additional form to the accomplishment of eccentric exercise's program in patients with chronic patellar tendinopathy is more effective than the accomplishment of an additional treatment with dry needling or eccentric exercise's program realized of isolated form.
Detailed Description
Experimental study randomized with double blind, whose purpose is to compare three protocols in those who apply different protocols of physical therapy to themselves in three groups of intervention with patients with chronic patellar tendinopathy.
There take part in this study young women of both sexes, of Zaragoza and of different sports clubs of entity 18 and 40 years, that they realize of habitual form (minimum 3 times a week) a sport. All of them present chronic patellar tendinopathy.
Study Design
- Study Type
- Interventional
- Allocation
- Randomized
- Intervention Model
- Parallel
- Primary Purpose
- Treatment
- Masking
- Triple (Participant, Investigator, Outcomes Assessor)
Eligibility Criteria
- Ages
- 18 Years to 40 Years (Adult)
- Sex
- All
- Accepts Healthy Volunteers
- No
Inclusion Criteria
- •Age understood between 18 and 40 years.
- •To practise any sport of habitual form.
- •Patients diagnosed of chronic patellar tendinopathy with a minimum of 3 months of evolution and with stable symptomatology.
- •Pain to the palpation of the tendon in the low pole of the knee and during the training or competition.
- •Punctuation of the questionnaire VISA-P under 80.
Exclusion Criteria
- •Patient had an operation on the knee affected in the last 6 months.
- •Infiltrations in the knee affected in the last 3 months.
- •Patient who has received pharmacological treatment or physical therapy in the last 48 hours.
- •Pathology with less than 3 months of evolution.
- •To present bilateral chronic tendinopathy.
- •Punctuation of the questionnaire major or equal Visa - p of
- •Inability to apply someone of the techniques of treatment or valuation for absolute or relative contraindication.
Arms & Interventions
Group of Dry Needling
They will receive a treatment of dry needling with ultrasound scan together with a treatment in which they will realize eccentric exercise's program that the patient will have to realize in his domicile.
The needle will get in the relevant zone of treatment. The punction will be realized using the technique of entry - Hong's rapid exit. Three punction will realize in the disabled zone of 3 seconds of duration.
Intervention: Group of Dry Needling (Other)
Group of electrolysis
They will receive a treatment of Intratissue Percutaneous Electrolysis with ultrasound scan together with a treatment in which they will realize eccentric exercise's program that the patient will have to realize in his domicile.
The needle will get in the relevant zone of treatment. An intensity of 3 milliampere will be in use, during 3 seconds and one will repeat 3 times.
Intervention: Group of Electrolysis (Other)
Control Group
They will receive a treatment of punction placebo with ultrasound scan together with a treatment in the one that will realize eccentric exercise's program that the patient will have to realize in his domicile.
Intervention: Control Group (Other)
Outcomes
Primary Outcomes
Change from baseline in functionality at 8 weeks as measured by Visa-p
Time Frame: 8 weeks
This scale consists of eight questions, the first six questions of which employ an analogical visual scale in order to assign a score of 0 to 10, where 10 represents the optimum state, for the purpose of quantifying pain and function in different activities, whereas the last two questions assess the level of functionality and ability to perform physical activity.
Secondary Outcomes
- Hypervascularity, as measured by ultrasound scan(0, 8 and 20 weeks)
- Pain, as measured by Visual Analog Scale(0, 8 and 20 weeks)
- Quality of life by SF-36(0, 8 and 20 weeks)
- Thickness of the tendon, as measured by ultrasound scan(0, 8 and 20 weeks)
- Height of the jump(0, 8 and 20 weeks)
- Concentric force of the low members(0, 8 and 20 weeks)
- Speed of the jump(0, 8 and 20 weeks)
- Functionality, as measured by Visa-p(0 and 20 weeks)
Investigators
Maria Pilar López Royo
Graduate
Universidad de Zaragoza